diclofenac

1. Basic Product Identification

INN Name: Diclofenac

Therapeutic Class: NSAID (Non-copyrightal Anti-Inflammatory Drug)

Common Salts: Diclofenac sodium, Diclofenac potassium

Dosage Forms:

Tablets (IR / SR)

Injectable solution

Topical gels / creams

Suppositories

Key Indications:

Pain & inflammation

Arthritis

Musculoskeletal disorders

Post-operative pain

Migraine (potassium salt fast acting)

2. Therapeutic Knowledge

Diclofenac is widely used for:

Osteoarthritis

Rheumatoid arthritis

Ankylosing spondylitis

Acute musculoskeletal pain

Post-surgical inflammation

Dysmenorrhea

Migraine (acute attack)

3. Mechanism of Action (MOA)

Diclofenac inhibits cyclooxygenase enzymes (COX-1 & COX-2).

Pathway:

↓ COX enzyme activity

↓ prostaglandin synthesis

Effects:

Anti-inflammatory

Analgesic (pain relief)

Antipyretic (fever reduction)

???? COX-2 preference slightly higher than older NSAIDs, but still non-selective.

4. Pharmacokinetics (ADME)

Absorption

Oral bioavailability: ~50–60%

Rapid absorption (especially potassium salt)

Distribution

~99% protein bound (albumin)

Metabolism

Hepatic (CYP2C9 major pathway)

Excretion

Urine (~65%)

Bile/feces (~35%)

Half-life:

1–2 hours (short), but duration diclofenac API Exporter from Sao Paulo extended due to tissue binding

5. Dosage & Administration

Oral:

50 mg 2–3 times daily

SR formulations: 75–100 mg once or twice daily

Injectable:

75 mg IM deep injection

Topical:

1% or 2% gel applied 2–4 times daily

Administration notes:

Take with food to reduce GI irritation

Use lowest effective dose for shortest duration

6. Formulation Knowledge

Oral tablets:

IR / enteric-coated / SR forms

Injectable:

Aqueous solution (often pH-adjusted with buffers)

Topical gels:

Carbomer-based gel systems

Alcohol + penetration enhancers

Key formulation challenges:

Poor water solubility

GI irritation (oral)

Stability in aqueous injectable forms

7. Raw Materials Knowledge

API:

Diclofenac sodium or potassium salt

Excipients:

Microcrystalline cellulose

Lactose / starch

Povidone (binder)

Magnesium stearate

Gel-forming polymers (topical)

Critical raw material concern:

Purity of intermediates (phenylacetic acid derivatives)

Control of impurities (chloroaniline-related)

8. Manufacturing Process Knowledge

API synthesis:

Multi-step organic synthesis:

Phenylacetic acid derivative formation

Chlorination + coupling reactions

Purification via crystallization

Tablet manufacturing:

Granulation (wet or dry)

Compression

Coating (enteric/SR if needed)

Gel manufacturing:

Polymer dispersion

API solubilization

Homogenization

Injectable:

Sterile solution preparation

Filtration (0.22 µm)

Aseptic filling

9. Analytical & QC Knowledge

Key tests:

HPLC assay

Related substances

Dissolution testing

Content uniformity

pH (injectable/topical)

Viscosity (gel)

Stability methods:

Photodegradation studies

Hydrolysis under pH stress

Thermal degradation profiling

10. Regulatory Knowledge

Status:

WHO essential medicine

Globally approved NSAID

Regulatory requirements:

Bioequivalence (oral forms)

Sterile validation (injectables)

Topical dermal absorption studies (gel products)

Label requirements:

GI bleeding risk

Cardiovascular risk warning

Long-term use caution

11. Storage & Stability

Store at 15–25°C

Protect from moisture & light

Stability risks:

Hydrolysis (especially injectable forms)

Photodegradation

Gel viscosity breakdown over time

12. Packaging Knowledge

Oral:

Alu-Alu blister (moisture protection)

Injectable:

Glass ampoules / vials

Topical:

Laminated aluminum tubes

Airless pump containers (premium)

13. Safety & Toxicology

Common side effects:

Gastric irritation

Nausea

Headache

Dizziness

Serious risks:

GI ulcer/bleeding

Cardiovascular thrombotic risk

Liver enzyme elevation

Renal impairment

Contraindications:

Active peptic ulcer

Severe heart disease (long-term use caution)

14. Market & Commercial Knowledge

Market type:

Massive global NSAID market

Competitors:

Ibuprofen

Naproxen

Aceclofenac

Etoricoxib (COX-2 selective)

Strength:

Strong prescription + OTC crossover (topical forms)

15. Intellectual Property (IP)

Original patents expired globally

Highly commoditized generic market

Innovation focus:

Topical delivery systems

Nano-formulations

Sustained release systems

16. Environmental & EHS Knowledge

API synthesis generates chlorinated organic waste

Wastewater treatment required

Gel manufacturing → solvent emissions control

Packaging waste (blisters, tubes)

17. Export Documentation Knowledge

Required documents:

DMF (API + finished product)

GMP certificate

COA (batch-wise)

Stability studies (ICH Q1A)

Validation reports (process + cleaning)

Bioequivalence reports

MSDS

18. Business Development Knowledge

Opportunities:

OTC pain relief segment

Hospital injectable tenders

Topical gel OTC markets (high growth)

Strategy:

Build strong dermatology + orthopedic presence

Focus on topical differentiation (gels, sprays)

Compete on price + brand trust

19. Advanced Technical Knowledge

COX inhibition is reversible and dose-dependent

High protein binding → drug interaction potential

Topical delivery bypasses systemic exposure

Fast potassium salt used for acute pain onset

NSAID class cardiovascular risk mechanism linked to prostaglandin imbalance

20. AI & Digital Knowledge (Modern Pharma)

AI applications:

Pain outcome prediction models

Topical absorption simulation

Supply chain demand forecasting

Pharmacovigilance signal detection (GI/cardiac risk patterns)

Digital pharma:

E-detailing for pain management products

Smart OTC recommendation systems

21. Sales Team Product Knowledge Checklist

Sales teams must know:

Difference between sodium vs potassium forms

GI risk counseling requirement

Short-term vs long-term use guidance

Topical advantage (fewer systemic effects)

Avoid use in high CV-risk patients (long-term)

22. Most Important Technical Documents

DMF (API & formulation)

Bioequivalence study report (oral)

Stability reports (ICH Q1A)

Photostability studies

Sterility validation (injectables)

Process validation reports

Cleaning validation

GMP certificate

23. Ultimate Pharma Product Mastery Summary

Diclofenac is:

A broad-spectrum NSAID with multiple delivery formats

Technically versatile:

Oral, injectable, topical

Commercially powerful:

High global demand in pain management

Manufacturing-critical:

API impurity control

Stability of injectable & gel forms

Leave a Reply

Your email address will not be published. Required fields are marked *